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Brown adipose tissue (BAT) is emerging as a potential target for treating human obesity. It has been indicated that BAT is rich in
innervations of sympathetic nerve control. Using 18F-FDG microPET imaging, this study aims at evaluating how factors related
to sympathetic activation/inhibition changed BAT metabolism of mice. BAT 18F-FDG uptake were semiquantitatively evaluated
in diﬀerent groups of mice under temperature (cold or warm stimulus) or pharmacological interventions (norepinephrine,
epinephrine, isoprenaline, or propranolol) and were compared with the corresponding controls. It was found that BAT activation
canbe stimulatedby cold exposure (P = 1.96×10
−4),norepinephrine (P = .002),orboth (P = 2.19×10
−6)wi t h i nanh ou rb e f or e
18F-FDG injection and can also be alleviated by warming up (P = .001) or propranolol lavage (P = .027). This preliminary study
indicated that BAT function could be evaluated by 18F-FDG PET imaging through short-term interventions, which paved the way
for further investigation of the relationship between human obesity and BAT dysfunction.
1.Introduction
Brown adipose tissue (BAT) is a kind of fat tissue diﬀerent
from white adipose tissue (WAT). In mammals, BAT has its
function mainly in nonshivering thermogenesis, responsible
for control of body temperature and regulation of energy
balance [1]. BAT is commonly found in human newborns
and small mammals, and it is previously thought that
there is only a vestigial amount of BAT in adulthood [2].
Recently, 18F-FDG PET/CT demonstrated a relatively broad
distribution of functional BAT in adulthuman, mainly along
the way of sympathetic nerve control, such as paravertebral
and periadrenal regions [3, 4]. These functional BATs have
drawn our attention as a potential therapeutic target for
inducingweight loss through itsenergy expenditure pathway
[2, 5], because excision or denervation of interscapular BAT
can produce abnormal increase in the amounts of WAT in
those animals, meaning that they are becoming fatter [6].
Some other studies, though showing limited success, have
already tried to activate BAT by stimulating SNS to control
body weight, using, for instance, β3-adrenoceptor agonists
CL-316243 or L-796568 [7, 8]. But none of them monitored
BAT metabolic function during their researches.
Cold stimulus has been proved to increase 18F-FDG
uptake, an indicator of BAT metabolism, in either animal
or human studies [9, 10]. Cold can activate sympathetic
nerve system (SNS) to excrete norepinephrine, and then
the BAT, which is rich in sympathetic nerve terminals, will
produce more heat [11]. Genomic studies have indicated
that the heat production is related to uncoupling protein 1
(UCP1), which is highly expressed in the mitochondria of
BAT cells and can convert glucose and free fatty acid into
heat [12]. Forfurther evaluation of how the inﬂuence factors
related to SNS changed the BAT metabolism, this study
investigated several interventions to stimulate or inhibit SNS
and BAT metabolism of mice, and under the application
of microPET, BAT metabolic statuses were clearly seen in
vivo,showing diﬀerentdegreeofFDGuptakeunderdiﬀerent
interventions which could be semiquantitatively analyzed in
real time. MicroPET served as a useful tool in monitoring2 Journal of Biomedicine and Biotechnology
BAT function under diﬀerent interventions and showed the
potential to guide further study of the relationship between
BAT metabolism and obesity and diabetes.
2.Materialsand Methods
2.1. Animals and Grouping. Five-to-ten-wk female Kunming
mice (provided by Beijing Medical College Animal Breeding
Center) were enrolled in this study (mean body weight =
25g). All animals were kept in the Animal Breading Center
of PUMCH with constant room temperature of 21◦C. Food
and water were given ad libitum. Control mice (n = 12)
were examined under room temperature of 20-21◦C. Three
intervention groups were involved in this study (Table 1).
In physical intervention group, mice were exposed to cold
(n = 6, 6◦C-7◦C, t = 1h), cold and then warm (n = 6,
6◦C-7◦C, t = 1h, and then 35 ◦C-36◦C, t = 1.5h), or
only warm (n = 6a n dt = 1.5h). For pharmacological
stimulation group, under 21◦C mice received intraperitoneal
injection of norepinephrine (NE, 0.4mg/kg, n = 5),
epinephrine (0.02mg/kg, n = 5), isoprenaline (0.016mg/Kg,
n = 6), respectively, or both cold and NE (NE: 0.04mg/kg,
n = 7). For pharmacological inhibition group, cold pre-
exposure mice received intragastric administration of pro-
pranolol (13.2mg/kg, n = 3) or saline (n = 3).
2.2. Temperature Interventions. Control mice were kept in
the examination room with constant temperature of 20◦C-
21◦Cwithoutphysicalinterventionorpharmacologicalstim-
ulation. For cold intervention, we put the mice in a plastic
box and kept them in a temperature-regulative refrigerator
(BC-185FA, Aucma, China) with a constant temperature of
6◦C-7◦C(measuredbyathermometerintherefrigerator)for
1h. For warm stimuli, we placed the mice in a plastic box
laidaboveapower-regulative heatingpad(ML-1.5-4,Tianjin
Tester Company, China) with the temperature of 35◦C-36◦C
(measured by a thermometer in the box) for 1h and kept
warming the mouse for 0.5h after FDG injection. All these
animals were provided with food and water supply during
the interventions.
2.3. Pharmacological Interventions. Norepinephrine (Tianjin
Jinhui Amino Acids Co.), epinephrine (Beijing Yongkang
Phar Co.), and isoprenaline (Shanghai Harvest Phar Co.)
were diluted with saline and injected into peritoneal cavity
of mouse in the volume of 100μL (0.4mg/kg), 100μL
(0.02mg/kg), and 30μL (0.016mg/Kg), respectively, 1h
before FDG injection. Propranolol tablets (Tianjin Lisheng
Phar Co.) were dissolved in saline to 1mg/mL and adminis-
tered intragastrically through a small animal lavage needle in
thevolumeof300μL(13.2mg/kg)permouse1hbeforeFDG
injection. To monitor the combination eﬀect of cold stimuli
andNE,weperformed thecoldstimuliprotocolasstatedand
gave NE injection with 0.04mg/kg 1h before FDG injection.
All of these pharmacological interventions were performed
under room temperature of 21◦C, and after interventions,
water and food were provided.
Table 1:Groups accordingtointerventionsandthenumberofmice
in each group.
Interventions Mouse number
Temperature intervention 18
Cold exposure 6
Cold exposure + warm stimuli 6
Warm stimuli 6
Pharmacologicalstimulation 23
Norepinephrine (NE) 5
epinephrine 5
isoprenaline 6
NE + cold exposure 7
Pharmacologicalinhibition 6
Cold + propranolol 3
Cold + saline 3
Controls 12
2.4. MicroPET Protocol. A l lm i c ew e r ee x a m i n e du n d e r
nonfasted status.Afterphysicalorpharmacologicalinterven-
tions, 3.7MBq 18F-FDG was injected into peritoneal cavity
for each mouse. Water and food was supplied after FDG
injection. Anesthesia usingSummitAS-1-000-7animal anes-
thesia system (USA) was performed with 1.5% isoﬂurane
(withO2 combinationof2literperminute)40minlater.PET
data acquisition procedure was performed under Siemens
Inveonsystem10min afteranesthesia when miceweretotally
unconscious. Acquisition procedure lasted for 300sec for
each mouse. Anesthesia was continued during the scanning
process with the same ﬂow rate through a facemask designed
for small animal.
2.5. Data Analysis. All microPET images were studied by
two researchers (Wu and Cheng) on a high-resolution
computer screen applying ASIPro VM software. Both visual
and semiquantitative analyses were performed for each
mouse. For visual analysis, the two researchers compared the
interscapular BAT 18F-FDG uptake color intensity of mouse
from diﬀerent intervention groups. For semiquantitative
analysis, 3D round regions of interests (ROI) were placed
carefully over the interscapular BAT and brain on microPET
images for each mouse, respectively. 18F-FDG uptake value
was acquired in the form of nanocurie per cubic centimeter
(nCi/cc) automatically after placing ROIs. Uptake ratio (R)
of maximum interscapular BAT uptake and mean brain
uptakewascalculatedforeachmouseandcomparedbetween
diﬀerent interventions.
2.6. Statistical Analysis. Data were reported as means ±
SD. Statistical analysis was performed using SPSS software,
Version 17.0. One way ANOVA was used, and P<. 05 was
considered signiﬁcant.Journal of Biomedicine and Biotechnology 3
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Figure 1: Comparison of interscapular BAT uptake in mice receiving diﬀerent interventions from microPET sagittal images. For visual
analysis, microPET images showed that mouse interscapular BAT 18F-FDG uptake (arrow) varied under diﬀerent interventions. (c) Cold
plus NE interventions showed highest BAT uptake (R = 15.64 ± 5.58, P = 2.19 × 10
−6) compared to (b) cold exposure (R = 10.22 ± 4.13,
P = 1.96 × 10
−4) and (a) control (R = 4.08 ± 1.32), while (d) warming (R = 2.13 ± 0.43, P = .001) and (e) propranolol (R = 1.30 ± 0.16,
P = .027) showed decreased BAT uptake in cold pre-exposure mice.
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Figure 2: Comparison of the eﬀects of diﬀerent interventions to stimulate interscapular BAT in mice. (a) BAT FDG uptake ratio in cold,
cold + NE and control group. Cold together with NE intervention showed the highest uptake in BAT. (b) BAT FDG uptake ratio in NE,
epinephrine, isoprenaline, and control group. All these pharmaceutics increase BAT activity, but only NE showed signiﬁcant diﬀerence
(P = .002).
3.Results
In visual analysis, diﬀerent interscapular BAT 18F-FDG
uptake intensity was found under diﬀerent interventions
as demonstrated by the microPET images (Figure 1). Cold
and NE exposure caused the highest BAT uptake, followed
by cold exposure and the control, while propranolol lavage
and warming up showed decreased BAT uptake in cold pre-
exposed mice.
In semiquantitative analysis, BAT 18F-FDG uptake was
signiﬁcantlyhigherundercoldexposurecomparedtocontrol
mice under room temperature (R:1 0 .22±4.13 versus 4.08±
1.32, P = 1.96 × 10
−4) and highest with both cold exposure
and NE stimulations (R:1 5 .64 ± 5.58 versus 4.08 ± 1.32,
P = 2.19 × 10−6). A stimulation with only NE (R:1 0 .55 ±
5.85), epinephrine (R:4 .57 ± 0.86), or isoprenaline (R:
4.64 ± 2.67) at room temperature all increased BAT uptake
compared with the controls (R:4 .08 ± 1.32), but only NE
showed signiﬁcant diﬀerence compared with the controls
(P = .002) (Figure 2).
For BAT inhibition, warming could signiﬁcantly reduce
BAT uptake in mice with cold pre-exposure (R:2 .13 ± 0.43
versus 10.22±4.13,P = .001)and withoutcoldpre-exposure
(R:2 .48 ± 0.88 versus 4.08 ± 1.32, P = .017). In addition,
propranolol could signiﬁcantly reduce BAT uptake in cold
pre-exposed mice(R:1.30±0.16versus3.09±0.90,P = .027)
(Figure 3).4 Journal of Biomedicine and Biotechnology
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Figure 3: Comparison of the eﬀects of warming and propranolol to inhibit interscapular BAT in mice. (a) BAT FDG uptake ratio under
warm intervention. Warming could signiﬁcantly decrease BAT metabolism in mice with or without cold pre-exposure (P = .001 and .017,
resp.).(b) BAT FDG uptakeratiounder propranololintervention.Propranololcould signiﬁcantlydecrease BAT activity incoldpre-exposure
mice (P = .027).
4.Discussion
Brown adipose tissue (BAT) has been shedding new light on
weight control of human recently, but few researches focused
on monitoring BAT metabolic function using molecular
imaging. It is well known that BAT has more sympathetic
innervations than WAT [13], which means that BAT may
be activated by stimulating SNS. For future investigation of
new methods to control obesity through activation of BAT
function, the present study aimed mainly at establishing a
technology platform using microPET to evaluate the BAT
function through interventions with factors related to SNS
activation or inhibition. Considering that the SNS might
probably be modulated by short-term interventions, the
temperature control or drug administration was generally
set as 1h before FDG injection in this study. Moreover,
peritoneal injection or lavage was used to obtain a more
stable eﬀect. The results proved that these choices were
feasible.
BAT can bring in false positive results in PET images of
human by showing increased radioactive uptake especially
in the supraclavicular area [14, 15]; many studies, therefore,
try to ﬁnd methods to inhibit BAT uptake in humans, for
instance, by keeping the patients warm or giving orally pro-
pranolol administration [16–18]. Our study provided new
data concerning these two methods in inhibiting BAT uptake
that only 1.5 hour of warm intervention (1h before and
0.5 hour after FDG injection) could quickly and markedly
inhibit BAT metabolism (R:2 .48 ± 0.88 versus 4.08 ± 1.32,
P = .017), and compared with propranolol intervention,
warming seemed to be more eﬀective in reducing BAT
activity (P = .001). Based on this result, in clinics, to prevent
BAT uptake in PET images, providing a warm environment
for patients right before PET scan would be a more eﬀective,
convenient, and safer way than propranolol intake.
Cold stimulus was proved useful to increase BAT
metabolism in either animal or human studies [9, 10]
because it can activated sympathetic nerve terminals sur-
rounding the BAT to excrete NE for more heat production
[11]. In our study, cold exposure also signiﬁcantly increased
BAT activity (R:1 0 .22 ± 4.13 versus 4.08 ± 1.32, P = 1.96 ×
10−4), and this eﬀect was more obvious when combined
with NE injection (P = 2.19 × 10
−6), well conﬁrming
that BAT metabolism was correlated with catecholamine
system. Moreover, cold eﬀect could be quicklysuppressed by
warming (R:2 .13 ± 0.43 versus 10.22 ± 4.13, P = .001) or
propranolol administration afterwards (R:1 .30±0.16 versus
3.09 ± 0.90, P = .027), both of which were antagonistic to
sympathetic-adrenal system, thus prohibiting BAT activity.
In our present study the β-adrenoceptor agonists (NE,
epinephrine and isoprenaline) all increased interscapular
BAT activity in mouse, but only NE showed a signiﬁcant dif-
ference to controls (P = .002,.459, and.293, resp.). We think
t h ed o s a g ei n s u ﬃciency of epinephrine and isoprenaline we
gave mice may answer this question. With limited researches
and few examples to follow, we gave a tentative dosage of
epinephrine (0.02mg/kg) and isoprenaline (0.016mg/Kg) to
mice, which is about the clinical dosage for children (about
half of adult dose), much smaller than the advised dose for
mouse (about 9-fold clinical dosage for adults) based on
surface area per kilogram [19]. However, the dosage of NE
(0.4mg/kg) we gave mice was 11 times the dosage forhuman
adult,so onlyNEwaseﬀectiveinactivating BATmetabolism.
Baba et al. [20] used epinephrine in 5mg/kg, and microPET
scan showed signiﬁcant BAT uptake compared to controls;
therefore, we think increasing dosage in future study may
overcome this problem.
There are some limitations in this study. For instance,
only female mice were enrolled in this study, and the mouse
number in each intervention group was not big enoughJournal of Biomedicine and Biotechnology 5
(n = 3 ∼ 7). Furthermore, some uncontrollable factors such
as environmental noise and stimuli caused by experimental
handling may potentially inﬂuence the nerve system of
mouse and thus the activity of BAT. In future studies, we will
make improvement in these aspects.
In general, this preliminary study gives new prospective
in studying the stimulation and inhibition of BAT of mouse
by a quantitative analyzing tool of microPET. By applying
microPET, the BAT activate status can be evaluated in vivo
semiquantitatively in real-time.
5.Conclusion
Environment temperature control can signiﬁcantly stimulate
or alleviate BAT uptake of 18F-FDG within 1h in mice.
Stimulating sympathetic nerve system by norepinephrine
can signiﬁcantly increase the metabolism of BAT within
1h, while inhibiting SNS by warming or propranolol can
alleviate BAT function. This preliminary study with 18F-FDG
microPET warrants further investigations of the mechanism
of BAT and various methods of intervention according to
clinical purposes. However, better optimization of diﬀerent
intervention conditions as well as some other methods for
activating BAT should be further explored and studied in the
hope of future human application.
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